Jeanie Larson
Family · Bismarck, NDNPI 1881347995
Payments from drug & device makers
Across 23 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$56
- Novo Nordisk$53
- Sanofi-aventis U.S. LLC$52
- Novartis$38
- Amarin Pharma, Inc.$33
- Amgen$30
- plus $95 from 5 others
What the payments were for
- Food & beverage$358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $56 |
| Novo Nordisk | 4 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Novartis | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $33 |
| Amgen | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $21 |
| AstraZeneca | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$358 in reported general payments places this provider in the 60th percentile of 496 family providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $46,456 |
| TrulicityDulaglutide | 23 | $21,523 |
| JanuviaSitagliptin Phosphate | 11 | $13,055 |
| XareltoRivaroxaban | 13 | $12,748 |
| MyrbetriqMirabegron | 17 | $9,957 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,398 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,023 |
| Celecoxib | 28 | $2,824 |
| Rosuvastatin Calcium | 64 | $1,455 |
| Losartan Potassium | 92 | $1,413 |
| Levothyroxine Sodium | 98 | $1,406 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $1,110 |
| Omeprazole | 65 | $1,103 |
| Clobetasol Propionate | 12 | $891 |
| SynthroidLevothyroxine Sodium | 12 | $829 |
Paid to pharmacies, not to this prescriber.
Other family in Bismarck
- Courtney WoodburyBismarck$8K
- Monica GoetzBismarck$8K
- Elizabeth ScheurerBismarck$6K
- Kayla HolzerBismarck$5K
- Amanda AllmarasBismarck$5K
- Kathryn StensgardBismarck$5K
- Sally FrankBismarck$4K
- Amy GotvasleeBismarck$4K
- Michelle MaierBismarck$4K
- Tanya GuthmillerBismarck$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.